SCHEMBL23872011

SCHEMBL23872011

CC(C)NCCOCCOCC(=O)NCCOCCOCC(=O)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 5/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
GLP1R P43220 8/20 0.34
ADRB2 P07550 4/20 0.33
HTR1A P08908 4/20 0.33
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21105824 0.91 KDM4E (0.43) MEN1KMT2AKDM4EPOLBTDP1
SCHEMBL861505 0.91 KDM4E (0.43) MEN1KMT2AKDM4EPOLBTDP1
SCHEMBL11956477 0.91 KDM4E (0.43) MEN1KMT2AKDM4EPOLBTDP1
SCHEMBL21925758 0.90 GLP1R (0.39) MEN1KMT2AKDM4EPOLBTDP1
SCHEMBL26706506 0.88 MEN1 (0.44) MEN1KMT2AKDM4EPOLBTDP1
SCHEMBL26706574 0.88 MEN1 (0.44) MEN1KMT2AKDM4EPOLBTDP1
SCHEMBL16543781 0.87 KDM4E (0.40) MEN1KMT2AKDM4EPOLBTDP1
SCHEMBL26020269 0.87 KDM4E (0.44) MEN1KMT2AKDM4ETDP1GLP1R
SCHEMBL26818481 0.87 MEN1 (0.37) MEN1KMT2AKDM4EPOLBTDP1
SCHEMBL26865995 0.87 MEN1 (0.41) MEN1KMT2AKDM4EPOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021193983-A2 QW DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-09-30 WO disclosed